Disclosure certainty 4/5 debate potential 2/5

Gil avoids daily longevity drugs, citing no high-impact market options

Elad Gil · How Silicon Valley’s Most Prolific Investor Picks Unicorns | Elad Gil Interview · Oct 8, 2024 · at 32:03

Investor and biology PhD Elad Gil is asked by Sam Parr whether he takes experimental longevity drugs or supplements like Metformin.

0:00 / 0:08exact quote · 8.7s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“I've tried to stay away from taking anything chronically, unless I think it would have a huge impact, and so far, there isn't anything in the market that would really map to that.”

quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →

More from Elad Gil

Insight
Elad Gil: Market Selection Matters More Than Founder Quality in Startups
“I tend to take more of a market first approach than most early stage people. I focus on the market and product market more than the founders. And obviously founders are incredibly important. I started two companies myself, so I hope that founders are incredibl…”
Elad Gil Oct 8, 2024 ▶ 2:06 How Silicon Valley’s Most Prolific Investor Picks Unicorns | Elad Gil Interview
Insight
Gil: Anduril Expands Defense Market Cap Through 50% Margins
“The traditional defense tech companies are what are known as cost plus, which means if you have a million dollar drone, they charge five percent. So they can't make more than five percent margins. They make 50 can a drone. You're Anduril. You can sell 10 bette…”
Elad Gil Oct 8, 2024 ▶ 11:34 How Silicon Valley’s Most Prolific Investor Picks Unicorns | Elad Gil Interview
Opinion
Gil: Predictions of massive two-person AI companies are highly overstated
“And so I think the future of two person companies, at least in the medium term, is very overstated. I think AI is largely going to be business as usual and certain types of teams are going to shrink a lot, right?”
Elad Gil Oct 8, 2024 ▶ 17:05 How Silicon Valley’s Most Prolific Investor Picks Unicorns | Elad Gil Interview
Prediction Not checkable as stated
Gil: AI Will Probably Cause Overall Shrinkage in Customer Success Jobs
“And that's an area where I think there'll be enormous leverage to existing customer success reps, but probably there's an overall shrinkage in that industry.”
Elad Gil Oct 8, 2024 ▶ 17:21 How Silicon Valley’s Most Prolific Investor Picks Unicorns | Elad Gil Interview
Insight
Gil shares Naval's model: mercenary to missionary to artist
“Naval's framework is is like, well, of course, early in your career, you're at least partially a mercenary. Otherwise you're never going to find the opportunity and go win it. And then later in your life, you're a missionary, right? You're not zero sum. You're…”
Elad Gil Oct 8, 2024 ▶ 20:14 How Silicon Valley’s Most Prolific Investor Picks Unicorns | Elad Gil Interview
Opinion
Gil: Schools do not need technology, just good teachers and curriculum
“I don't think there's any need for technology. I think you just need a couple good teachers and like a reasonable curriculum.”
Elad Gil Oct 8, 2024 ▶ 24:05 How Silicon Valley’s Most Prolific Investor Picks Unicorns | Elad Gil Interview
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 300 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.